English

Investor relations
Investor Relations

首页 > Investor relations

Information disclosure
Announcements and circulars Listing document Performance report
  1. 2024-09-23

    Voluntary Announcement - Data from the Phase Ib interim study of M701 malignant pleural effusion were presented at the 2024 ESMO meeting
  2. 2024-09-16

    2024 Interim Report
  3. 2024-09-04

    Monthly Return of equity Issuer on movements in Securities for the month ended 31 August 2024
  4. 2024-08-29

    Interim results announcement for the six months ended 30 June 2024
  5. 2024-08-29

    List of directors and their roles and functions
  6. 2024-08-29

    Proposed amendments to the articles of Association and appointment of nomination Committee members and compliance with listing rules
  7. 2024-08-27

    Inside information announcement
  8. 2024-08-19

    Date of board meeting
  9. 2024-08-05

    Monthly return of equity Issuer on movements in securities for the month ended 31 July 2024
  10. 2024-07-30

    List of directors and their roles and functions
<123456
首页 About us Science and technology Product & Development Investor relations News center Career development
电话：
027-82668988

Email: info@by-stuart.com

Add: Building C2-1, Optics Valley Biologic City, No. 666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan City, Hubei Province

分享
Copyright ©2014-2022 YZYBIO All rights reserved E ICP for 2022016887-1
" class="hidden">烟台论坛